Daniel J. O'Connor
2017 - Advaxis
In 2017, Daniel J. O'Connor earned a total compensation of $6.9M as Former President and Chief Executive Officer at Advaxis, a 5% increase compared to previous year.
Compensation breakdown
| Bonus | $209,271 |
|---|---|
| Option Awards | $2,724,045 |
| Salary | $354,718 |
| Stock Awards | $2,718,026 |
| Other | $911,045 |
| Total | $6,917,105 |
O'Connor received $2.7M in option awards, accounting for 39% of the total pay in 2017.
O'Connor also received $209.3K in bonus, $354.7K in salary, $2.7M in stock awards and $911K in other compensation.
Rankings
In 2017, Daniel J. O'Connor's compensation ranked 1,194th out of 14,666 executives tracked by ExecPay. In other words, O'Connor earned more than 91.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,194 out of 14,666 | 92nd |
Division Manufacturing | 400 out of 5,768 | 93rd |
Major group Chemicals And Allied Products | 107 out of 2,074 | 95th |
Industry group Drugs | 74 out of 1,730 | 96th |
Industry Pharmaceutical Preparations | 59 out of 1,329 | 96th |
Source: SEC filing on February 6, 2018.
O'Connor's colleagues
We found four more compensation records of executives who worked with Daniel J. O'Connor at Advaxis in 2017.
News
OncoSec Medical CEO Daniel O'Connor's 2021 pay jumps 122% to $3M
May 31, 2022
OncoSec Medical CEO Daniel O'Connor's 2020 pay rises 15% to $1.4M
March 18, 2021
OncoSec Medical CEO Daniel O'Connor's 2019 pay falls 72% to $1.2M
April 30, 2020
OncoSec Medical CEO Daniel O'Connor's 2018 pay falls 39% to $4.2M
November 8, 2018